Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Income from Non-Controlling Interests (2016 - 2022)

Aethlon Medical (AEMD) has disclosed Income from Non-Controlling Interests for 11 consecutive years, with $413.0 as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Income from Non-Controlling Interests rose 166.61% year-over-year to $413.0, compared with a TTM value of $413.0 through Jun 2023, up 110.14%, and an annual FY2022 reading of -$4794.0, changed 0.08% over the prior year.
  • Income from Non-Controlling Interests was $413.0 for Q1 2023 at Aethlon Medical, up from -$413.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $413.0 in Q1 2023 and bottomed at -$3982.0 in Q1 2019.
  • Average Income from Non-Controlling Interests over 5 years is -$1310.6, with a median of -$1135.0 recorded in 2021.
  • The sharpest move saw Income from Non-Controlling Interests tumbled 47.8% in 2021, then surged 166.61% in 2023.
  • Year by year, Income from Non-Controlling Interests stood at -$1358.0 in 2019, then dropped by 10.31% to -$1498.0 in 2020, then plummeted by 47.8% to -$2214.0 in 2021, then soared by 81.35% to -$413.0 in 2022, then skyrocketed by 200.0% to $413.0 in 2023.
  • Business Quant data shows Income from Non-Controlling Interests for AEMD at $413.0 in Q1 2023, -$413.0 in Q2 2022, and -$620.0 in Q1 2022.